P3 Health Partners vs Privia Health
PIII and PRVA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PIII and PRVA compare
Privia Health is the larger company, worth 160 times as much as P3 Health Partners ($3.1B against $19.6M).
Privia Health grew revenue faster over the last twelve months (19.2% versus 7.5% for P3 Health Partners).
Privia Health keeps more of each dollar of sales as profit, with a net margin of 1.4% compared with −3.3% at P3 Health Partners.
Privia Health scores higher on the StockData Score (16 against 4 for P3 Health Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PIII | PRVA |
|---|---|---|
| Size and price | ||
| Market cap | $19.6M | $3.1B |
| Share price | $2.70 | $24.55 |
| Change, 1 year | −64.6% | 1.4% |
| Change, 5 years | −99.5% | −14.9% |
| Beta (5Y) | 1.16 | 0.66 |
| Employees | 320 | 1,226 |
| StockData Score | ||
| Total score | 4 | 16 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 2 | 4 (better) |
| Health score | 0 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 94.4× |
| P/S | 0.0× (better) | 1.3× |
| P/B | – | 3.8× |
| EV/EBITDA | 36.9× (better) | 43.0× |
| Fair value | – | $15.32 |
| Margin of safety | – | −60.2% |
| Growth | ||
| Revenue growth (TTM) | 7.5% | 19.2% (better) |
| Revenue growth, 5Y average | 24.3% (better) | 21.0% |
| Net income growth (TTM) | – | 91.3% |
| EPS growth (TTM) | – | 100% |
| EPS growth, 5Y average | – | −11.4% |
| Profitability | ||
| Operating margin | −5.2% | 2.1% (better) |
| Net margin | −3.3% | 1.4% (better) |
| Return on equity | – | 4.6% |
| Return on invested capital | −32.7% | 10.0% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Net debt / EBITDA | 28.58 | – |
| Current ratio | 0.53 | 1.63 (better) |
| Altman Z-score | 0.29 | 4.60 (better) |
| Piotroski F-score | 2 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 65.0% | 96.7% |
| Held by insiders | 98.0% | 7.1% |
| Insider net buying, 12 months | −$824K (better) | −$22.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 3.3% |
Go deeper
- PIII stock overview
- PIII income statement
- PIII valuation and score
- PRVA stock overview
- PRVA income statement
- PRVA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.